Pfizer Pharma GmbH
Industry / private company
Location:
Berlin,
Germany (DE)
ISNI: 0000000449048590
ROR: https://ror.org/00m8w3m39
Show on Map:
Sirolimus in renal transplant recipients with malignancies in Germany (2021)
Naik MG, Arns W, Budde K, Diekmann F, Eitner F, Gwinner W, Heyne N, et al.
Journal article
Assessment of prognosis by established prognosis scores and physicians' judgement in mRCC patients: an analysis of the STAR-TOR registry (2020)
Boegemann M, Goebell P, Woike M, Buncke J, Schlack K, Schrader AJ
Journal article
Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort (2015)
Sievers C, Baur DM, Schwanke A, Buchfelder M, Droste M, Mann K, Stalla GK
Journal article
Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels (2014)
Droste M, Domberg J, Buchfelder M, Mann K, Schwanke A, Stalla G, Strasburger CJ
Journal article